Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is ...

Prostate cancer is one of the most common cancers affecting men, particularly those over 50. The disease can often grow silently in its early stages, with few obvious symptoms. Because of this, early ...

Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...

So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Because most of the major risk factors are beyond your control, there’s no proven way to truly reduce ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

JNJ secures FDA approval to expand Akeega into earlier-stage prostate cancer, backed by strong phase III data and a ...